GlassScriptPhysician profile
Richard Kline
NPI 1992447759
$7,273.56
in general payments reported to CMS, 2019-2025
10 companies · $2,558 in 2025
The $2,558 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,476 · 2023: $219 · 2024: $2,021 · 2025: $2,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308 · Grant: $1,250 · Travel and Lodging: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.79 |
| Grant | $1,250.00 |
| Travel and Lodging | $1,239.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,610.13 | 2024-2025 | Velys |
| Pinnacle, INC | $2,408.41 | 2022 | |
| Stryker Corporation | $1,114.13 | 2022-2025 | Mako, Accolade, Aequalis Ascend Flex |
| Depuy Synthes Sales INC. | $442.56 | 2024-2025 | Na, Attune, Tfn-Advance |
| Kuros Biosciences USA, INC | $154.49 | 2025 | Magnetos |
| Heron Therapeutics, INC. | $124.74 | 2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $124.74 | 2025 | |
| Convatec INC. | $124.27 | 2023 | |
| Polynovo North America LLC | $87.84 | 2024 | Novosorb Btm |
| Si-Bone, INC. | $82.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.